期刊文献+

系统性红斑狼疮病因病理与防治的思考 被引量:2

Consideration about Etiopathogenisis,Pathology and Therapy of Systemic Lupus Erythematosus
下载PDF
导出
摘要 系统性红斑狼疮(SLE)是一种临床表现有多系统损害症状的慢性系统性自身免疫病。虽然对SLE的病因、病理的研究有了较大的进展,但SLE的治疗并不理想,目前仍然有约10%的患者在发病5年内死亡。从哲学角度对SLE的病因、病理与防治中存在的问题进行了综合分析,并为SLE的临床实践和进一步研究提供了思路。 Systemic lupus erythernatosus (SLE) is a chronic autoimmune disease characterized by involvement with a broad spectrum of clinical manifestations. Ideal therapeutic approaches still haven't been available. Currently, about 10 % patients died within five years after diagnosis . This dissertation synthetically analyses etiopatbogenisis, pathology , and therapy of SLE in philosophical view , and find a better way for clinical practice and further study.
作者 代巧妹
出处 《医学与哲学(B)》 2007年第4期62-64,共3页 Medicine & Philosophy(B)
关键词 系统性红斑狼疮 病因 病理 防治 systemic lupus erythernatosus, etiopathogenisis, pathology, therapy
  • 相关文献

参考文献4

二级参考文献54

  • 1[1]Lander SA,Wallace DJ,Weisman MH.Celecoxib for systemic lupus erythematosus:case series and literature review of the use of NSAIDs in SLE[J].Lupus,2002,11 ( 6 ) :340.
  • 2[2]Rahman P,Gladman DD,Urowitz MB,et al. The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs[J].J Rheumatol, 1999,26 ( 2 ) :325.
  • 3[3]Levy RA,Vilela VS,Cataldo MJ,et al.Hydroxychloroquine(HCQ)in lupus pregnancy:double-blind and placebo-controlled study[J].Lupus,2001,10( 6 ) :401.
  • 4[4]Espinola RG,Pierangeli SS,Gharavi AE,et al. Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies[J].Thromb Haemost, 2002,87 ( 3 ): 518.
  • 5[5]Tseng C,Buyon J,Belmont HM,et al. Moderate dose steroids prevent severe flares of serologically active,clinically stable SLE patient[J].Arthritis Rheum,2003,48:S260.
  • 6[6]Sato EI.Methotrexate therapy in systemic lupus erythematosus[J].Lupus ,2001,10 ( 3 ): 162.
  • 7[7]Houssiau FA,Vasconcelos C,D'Cruz D,et al. Immunosuppressive therapy in lupus nephritis. The Euro-Lupus Nephritis Trial,a randomized trial of low-dose versus high-dose intravenous cyclophosphamide[J].Arthritis Rheum,2002,46:2121.
  • 8[8]Nossent HC,Koldingsnes W.Long-term efficacy of azathioprine treatment for proliferative lupus nephritis[J].Rheumatology (Oxford ) ,2000,39:969.
  • 9[9]Levy Y,Sherer Y,George J,et al.Intravenous immunoglobulin treatment of lupus nephritis[J].Senin Arthritis Rheum,2000,29:321.
  • 10[10]Ordi-Ros J,Cortes F,Cucurull E,et al.Thalidomide in the treatment of cutaneous lupus refractory to coventionl therapy[J].J Rheumatol, 2000,27:1429.

共引文献29

同被引文献23

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部